Fresh2 Group Ltd (FRES) - Multiplikator Forward P/S

Lambang korporat lan logo Fresh2 Group (FRES)

Fresh2 Group Limited is implementing ESG standards in B2B logistics to minimize its carbon footprint. Stable demand is driven by software for verifying the safety of agricultural products from China. Simultaneously, the company is expanding its staff of IT specialists and laboratory technicians. The forward revenue multiple illustrates the current business valuation, while 1.20 marks a new level, determining the balance between yield and investor risk.

FRES Fresh2 Group: Rasio kapitalisasi marang dodolan sing dikarepake ing interval 21.02.2024 - 30.09.2024

Ringkesan rincian data analitis fresh2.co (FRES)

- rega pasar lan target rega analis:
Bagan rega Fresh2 Group|FRES - Konsensus nilai wajar
- indikator kapitalisasi pasar:
Kapitalisasi pasar Fresh2 Group Limited|FRES - Total Nilai Perusahaan
- statistik nilai buku emiten:
Aset Bersih saben Siji Saham Fresh2 Group|FRES - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku fresh2.co|FRES - Nilai Agregat Aset
- data utang lan likuiditas:
Utang marang Ekuitas Fresh2 Group Limited|FRES - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Fresh2 Group|FRES - Gunggung utang perusahaan|Utang marang aset resik Fresh2 Group Limited|FRES - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Fresh2 Group|Likuiditas darurat fresh2.co
- data bathi bisnis lan rasio investasi:
FRES - Penghasilan resik|Proyeksi bathi mangsa ngarep Fresh2 Group Limited|FRES - Rasio rega marang bathi|Rasio rega marang bathi sing dikarepake Fresh2 Group|FRES - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Fresh2 Group Limited|FRES - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Fresh2 Group|FRES - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan fresh2.co|FRES - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Fresh2 Group Limited
- indikator volume dodolan lan pendapatan:
FRES - Pendapatan lan volume dodolan|Dodolan mangsa ngarep perusahaan Fresh2 Group|FRES - Kapitalisasi marang pendapatan|Rasio rega marang pendapatan sing dikarepake Fresh2 Group Limited
Analisis fundamental perusahaan:Fresh2, FRES
Produk asli Fresh2 Group Ltd

The trade confrontation between the US and China creates risks for Fresh2 Group Limited (FRES) logistics, making the monitoring of the expected P/S multiple critically important. This indicator compares current market capitalization with projected annual revenue, allowing investors to determine if the price is overheated relative to actual business scaling and to assess the company's fundamental margin of safety amid declining profitability.

Karo sapa Fresh2 Group Limited saingan

Rasio rega marang prakiraan pendapatan Agilent A|Rega forward marang dodolan DGX|Illumina Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Exact Sciences Inc.|Revvity, Inc. (RVTY) - Rasio rega marang prakiraan pendapatan|BIO - Rasio kapitalisasi marang dodolan sing dikarepake|NNNN (Anbio) - Multiplikator Forward P/S|SHC: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan QuidelOrtho Corp (QDEL)|Multiplikator forward rega marang pendapatan OPKO Health Corp. OPK|Rega forward marang dodolan CareDx, Inc|Multiplikator Forward P/S maravai.com MRVI|Prakiraan rega marang pendapatan FLGT|LAB: Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan Cytek Bio CTKB|OSUR (OraSure Corp) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep XGN (Exagen Inc)|Multiplikator forward rega marang pendapatan mdxhealth.com (MDXH)|Multiplikator Forward P/S LUCD|Rasio rega marang prakiraan pendapatan PRE (prenetics.com)|Insight Molecular Diagnostics Inc (IMDX) - Rega mangsa ngarep marang pendapatan|TRIB - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan ProPhase Labs, Inc. (PRPH)|AIMD: Rasio rega marang prakiraan pendapatan|Co-Diagnostics (CODX) - Rasio rega marang prakiraan pendapatan|Heart Test Laboratories, Inc. (HSCS) - Multiplikator Forward P/S|BMRA: Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan CDIO|Multiplikator forward rega marang pendapatan ONCO (Onconetix, Inc.)|Multiplikator Forward P/S viraxbiolabs.com (VRAX)|Rasio kapitalisasi marang dodolan sing dikarepake BJDX|AWH - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake Accelerate Diagnostics, Inc AXDX|CNTG - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ENZ|Genetic Technologies Limited (GENE) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan 23andMe (ME)|Multiplikator Forward P/S Psychemedics Corp.